drugset / Trial / NCT00903279

Treatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint Surgery

NCT00903279 ↗

Phase 2 Withdrawn Bay Pines VA Healthcare System
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators anticipate that utilization of retapamulin preoperatively will eliminate MRSA colonization among patients who are colonized in their nares.

Timeline

Start
2009-08
Primary completion
—
Completion
2010-12

Outcome

Outcome not reported

Stopped (Business): “Funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Retapamulin Small molecule 0.25 ml Intranasal
Subject Retapamulin Small molecule 1 % Intranasal